PubRank

Gerald J Beck

Author PubWeight™ 120.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 In-center hemodialysis six times per week versus three times per week. N Engl J Med 2010 10.73
2 Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002 10.52
3 A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003 9.18
4 Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007 7.93
5 Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 2008 7.50
6 Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2008 5.90
7 The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int 2011 4.27
8 The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med 2005 4.15
9 Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis 2010 3.87
10 Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med 2009 3.69
11 Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis 2008 3.34
12 A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas. N Engl J Med 2015 2.88
13 Uric acid and long-term outcomes in CKD. Am J Kidney Dis 2009 2.86
14 Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med 2007 2.71
15 Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol 2003 2.21
16 C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 2005 2.13
17 Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 2005 2.07
18 Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney Int 2010 1.88
19 Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: results of a randomized trial. J Natl Cancer Inst 2003 1.79
20 Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial. J Natl Cancer Inst 2007 1.73
21 Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 2006 1.70
22 Body mass index and mortality in CKD. Am J Kidney Dis 2007 1.68
23 Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration. Clin J Am Soc Nephrol 2010 1.65
24 Relationship between homocysteine and mortality in chronic kidney disease. Circulation 2006 1.58
25 Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney Int 2010 1.55
26 Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. Am J Kidney Dis 2005 1.49
27 Use of aspirin associates with longer primary patency of hemodialysis grafts. J Am Soc Nephrol 2011 1.49
28 Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. Am J Kidney Dis 2003 1.42
29 Serum bicarbonate and long-term outcomes in CKD. Am J Kidney Dis 2010 1.35
30 Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial. Clin Trials 2005 1.31
31 Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study. Kidney Int 2002 1.20
32 Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis 2006 1.19
33 Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials. Am J Kidney Dis 2010 1.19
34 Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging 2012 1.16
35 Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study. Am J Kidney Dis 2006 1.14
36 Predictors of sudden cardiac death: a competing risk approach in the hemodialysis study. Clin J Am Soc Nephrol 2011 1.07
37 Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease. Clin J Am Soc Nephrol 2010 1.01
38 Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling. Clin J Am Soc Nephrol 2013 0.98
39 Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease. Clin J Am Soc Nephrol 2009 0.96
40 Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial. Clin Trials 2005 0.96
41 Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. J Am Soc Nephrol 2005 0.95
42 β-Blockers for prevention of sudden cardiac death in patients on hemodialysis: a propensity score analysis of the HEMO Study. Am J Kidney Dis 2011 0.92
43 Accuracy of a GFR estimating equation over time in people with a wide range of kidney function. Am J Kidney Dis 2012 0.89
44 Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials. Circ Heart Fail 2010 0.84
45 Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study. Am J Kidney Dis 2013 0.82
46 Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitamins. Kidney Int 2005 0.81
47 Factors associated with lipoprotein(a) in chronic kidney disease. Am J Kidney Dis 2005 0.80
48 Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. Am J Kidney Dis 2002 0.75